haring clinical trial data is critical to the advancement of science, medicine and public health. It furthers our understanding of diseases, expands the base of knowledge needed to develop new treatments and generates new insights to inform decisions that will help the greatest number of people.
Johnson & Johnson honors the people who volunteer to participate in clinical trials by ensuring their data are shared responsibly. Since 2014, Johnson & Johnson has partnered with the Yale University Open Data Access (YODA) Project to enable a fair and unbiased approach for assessing external research proposals requiring the use of clinical trial data from our Pharmaceutical and MedTech sectors.
Five-year data on the YODA Project were published in Nature’s open access journal, Scientific Data, in 2018. The research findings illustrate best practices for sharing clinical trial data and outstanding challenges limiting broader adoption of responsible data sharing principles.